FindTrial
Sign In

A clinical trial for autologous airway basal cell transplantation in treatment of idiopathic pulmonary fibrosis

A before-after controlled study for autologous airway basal cell transplantation in treatment of idiopathic pulmonary fibrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018335
Enrollment
Unknown
Registered
2018-09-12
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

idiopathic pulmonary fibrosis

Interventions

Case series:autologous airway basal cell transplantation

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40-75 years old; 2. moderate or sevre decrease of DLco; 3. Interstitial lung disease change on lung CT; 4. Agree to join clinical trial and signature on informed consent; 5. Has a good compliance,can complete the examination and treatment; 6. Can complete the bronchoscopy and lung function examination.

Exclusion criteria

Exclusion criteria: 1. Can not tolerate the cell transplantation; 2. Has lung infection and need antibiotics treatment; 3. Combined with malignant tumor; 4. Has other disease or organ dysfunction; 5. Pregnant woman or had plan to have a baby; 6. Researcher's disagreement.

Design outcomes

Primary

MeasureTime frame
forced vital capacity;—

Countries

China

Contacts

Public ContactYi Lu

Shanghai Sixth People's Hospital

luyi0718@126.com+86 18930172985

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026